Zhang Q - Search Results

1

Thiolated Nanoparticles Overcome the Mucus Barrier and Epithelial Barrier for Oral Delivery of Insulin.

Zhou S, Deng H, Zhang Y, Wu P, He B, Dai W, Zhang H, Zhang Q, Zhao R, Wang X. Zhou S, et al. Among authors: zhang q, zhang h, zhang y. Mol Pharm. 2020 Jan 6;17(1):239-250. doi: 10.1021/acs.molpharmaceut.9b00971. Epub 2019 Dec 18. Mol Pharm. 2020. PMID: 31800258

2

[Study on pharmaceutical characterization and pharmacokinetics of daunorubicin long-circulating liposomes in rat].

Zhang H, Qi XR, Zhang Q. Zhang H, et al. Among authors: zhang q. Yao Xue Xue Bao. 2002 Apr;37(4):299-303. Yao Xue Xue Bao. 2002. PMID: 12579828 Chinese.

3

A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.

Jia Z, Lin P, Xiang Y, Wang X, Wang J, Zhang X, Zhang Q. Jia Z, et al. Among authors: zhang q, zhang x. Eur J Pharm Biopharm. 2011 Sep;79(1):126-34. doi: 10.1016/j.ejpb.2011.05.009. Epub 2011 May 30. Eur J Pharm Biopharm. 2011. PMID: 21658449

4

Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature.

Yang T, Wang Y, Li Z, Dai W, Yin J, Liang L, Ying X, Zhou S, Wang J, Zhang X, Zhang Q. Yang T, et al. Among authors: zhang q, zhang x. Nanomedicine. 2012 Jan;8(1):81-92. doi: 10.1016/j.nano.2011.05.003. Epub 2011 May 20. Nanomedicine. 2012. PMID: 21664295

5

Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.

Zhang JY, He B, Qu W, Cui Z, Wang YB, Zhang H, Wang JC, Zhang Q. Zhang JY, et al. Among authors: zhang q, zhang h. J Microencapsul. 2011;28(6):528-36. doi: 10.3109/02652048.2011.590614. Epub 2011 Jun 27. J Microencapsul. 2011. PMID: 21702701

6

Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat.

Wang XQ, Fan JM, Liu YO, Zhao B, Jia ZR, Zhang Q. Wang XQ, et al. Among authors: zhang q. Int J Pharm. 2011 Oct 31;419(1-2):339-46. doi: 10.1016/j.ijpharm.2011.08.003. Epub 2011 Aug 9. Int J Pharm. 2011. PMID: 21843612

7

The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.

Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Zhang Y, et al. Among authors: zhang q, zhang h, zhang x. Biomaterials. 2012 Jan;33(2):679-91. doi: 10.1016/j.biomaterials.2011.09.072. Epub 2011 Oct 22. Biomaterials. 2012. PMID: 22019123

8

Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against Parkinson's disease in the MPTP-induced mice model.

Xiang Y, Wu Q, Liang L, Wang X, Wang J, Zhang X, Pu X, Zhang Q. Xiang Y, et al. Among authors: zhang q, zhang x. J Drug Target. 2012 Jan;20(1):67-75. doi: 10.3109/1061186X.2011.595490. J Drug Target. 2012. PMID: 22149216

9

Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.

Zhang Y, Wang J, Bai X, Jiang T, Zhang Q, Wang S. Zhang Y, et al. Among authors: zhang q. Mol Pharm. 2012 Mar 5;9(3):505-13. doi: 10.1021/mp200287c. Epub 2012 Feb 1. Mol Pharm. 2012. PMID: 22217205

10

Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms.

Zhao S, Dai W, He B, Wang J, He Z, Zhang X, Zhang Q. Zhao S, et al. Among authors: zhang q, zhang x. J Control Release. 2012 Mar 28;158(3):413-23. doi: 10.1016/j.jconrel.2011.12.018. Epub 2011 Dec 29. J Control Release. 2012. PMID: 22226779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70,025 results

Search Page

Filters